학술논문
γ-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, first-in-human trial
Document Type
Article
Author
Source
In: The Lancet Oncology . (The Lancet Oncology, July 2023, 24(7):811-822)
Subject
Language
English
ISSN
14745488
14702045
14702045